{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:12:15Z","timestamp":1789398735744,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"DOI":"10.13039\/501100008349","name":"Universit\u00e4t Duisburg-Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Hintergrund<\/jats:title>\n                    <jats:p>Opioidlangzeitanwendungen (&gt;\u202f3\u00a0Monate) k\u00f6nnen ein wichtiger Bestandteil der Behandlung von Menschen mit chronischen Schmerzen sein, werden aber auch im Zusammenhang mit Risiken f\u00fcr die Entstehung von Opioidgebrauchsst\u00f6rung diskutiert. Ziel war es, die \u00e4rztliche Perspektive auf Risikofaktoren f\u00fcr die Entstehung von Opioidgebrauchsst\u00f6rungen, Barrieren f\u00fcr deren Identifikation und Ansatzpunkt zur \u00dcberwindung dieser Barrieren zu erheben.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodik<\/jats:title>\n                    <jats:p>\n                      Im Herbst 2021 fand eine schriftliche Querschnittsbefragung von 1854 \u00c4rzten in der vertrags\u00e4rztlichen Versorgung in Deutschland statt. Angeschrieben wurde eine Zufallsstichprobe von 1300 \u00c4rzten aus dem Pool eines Adressanbieters sowie die Mitglieder des BVSD (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u2009554). Im Januar 2022 wurde ein Reminder versandt.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ergebnisse<\/jats:title>\n                    <jats:p>An der Erhebung beteiligten sich 422 \u00c4rzte, ein Drittel (33\u202f%) war haus\u00e4rztlich t\u00e4tig und 65\u202f% besa\u00dfen die Zusatzweiterbildung \u201eSpezielle Schmerztherapie\u201c. Auf einer Skala von 1\u202f=\u2009volle Zustimmung bis 5\u202f=\u2009volle Ablehnung wurde in der Behandlung der chronischen Schmerzen durch mehrere \u00c4rzte das gr\u00f6\u00dfte Risiko f\u00fcr Missbrauch und Abh\u00e4ngigkeit gesehen (Mittelwert [MW] 1,33, Standardabweichung [SD] 0,596), gefolgt von behandlungsseitigen Risikofaktoren. Gr\u00f6\u00dfte H\u00fcrde f\u00fcr die Identifikation von Opioidgebrauchsst\u00f6rungen waren absichtliches Verschleiern durch Patienten (MW 1,73\/SD 0,888) sowie Opioidverordnung durch mehrere \u00c4rzte (MW 1,79\/SD 0,635). Der wichtigste Ansatzpunkt f\u00fcr die Aufdeckung m\u00f6glicher Opioidgebrauchsst\u00f6rungen wurde in der regelm\u00e4\u00dfigen Kontrolle der verordneten Menge (MW 1,37\/SD 0,648) sowie einem regelm\u00e4\u00dfigen Patientenkontakt (MW 1,49\/SD 0,654) gesehen.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diskussion<\/jats:title>\n                    <jats:p>Die vorliegende Studie quantifiziert \u00e4rztliche Einsch\u00e4tzungen zu strukturellen und behandlungsseitigen Risikofaktoren im deutschen Kontext. Diese k\u00f6nnen wichtige Ansatzpunkte f\u00fcr die Entwicklung gesundheitspolitischer Ma\u00dfnahmen bieten und deuten darauf hin, dass einer F\u00f6rderung der Transparenz und Kommunikation eine wichtige Bedeutung zukommt.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00482-026-00971-4","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:55:27Z","timestamp":1789397727000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Opioidgebrauchsst\u00f6rungen im Rahmen der Opioidlangzeitbehandlung","Opioid use disorders during long-term opioid treatment"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9077-7005","authenticated-orcid":false,"given":"Silke","family":"Neusser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Frederik","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Blase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Weitzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Abels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Speckemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cordula","family":"Riederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Nadstawek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Stra\u00dfmeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Wasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"971_CR1","unstructured":"Neusser S, Niemann A, Schrader NF, Blase N, Weitzel M, Abels C, Giebel GD, Speckemeier C, Riederer C, Nadstawek J, Stra\u00dfmeir W, Wasem J. Opioidhaltige Analgetika - Untersuchung zu Entwicklungstrends in der Versorgung bei nicht-tumorbedingten Schmerzen. Ergebnisbericht (F\u00f6rderkennzeichen\u00a001VSF19059). (last accessed on 20. Juli 2026) https:\/\/innovationsfonds.g-ba.de\/downloads\/beschluss-dokumente\/1139\/2026-05-22_Op-US_Ergebnisbericht.pdf"},{"issue":"11","key":"971_CR2","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1111\/add.16616","volume":"119","author":"KH Thomas","year":"2024","unstructured":"Thomas\u00a0KH, Dalili\u00a0MN, Cheng\u00a0HY et\u00a0al (2024) Prevalence of problematic pharmaceutical opioid use in patients with chronic non-cancer pain: A\u00a0systematic review and meta-analysis. Addiction 119(11):1904\u20131922. https:\/\/doi.org\/10.1111\/add.16616 (Epub 2024 Aug\u00a07. PubMed PMID: 39111346)","journal-title":"Addiction"},{"issue":"5","key":"971_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.annemergmed.2019.04.019","volume":"74","author":"A Cragg","year":"2019","unstructured":"Cragg\u00a0A, Hau\u00a0JP, Woo\u00a0SA et\u00a0al (2019) Risk factors for misuse of prescribed opioids: A systematic review and meta-analysis. Ann Emerg Med 74(5):634\u2013646. https:\/\/doi.org\/10.1016\/j.annemergmed.2019.04.019 (Epub 2019 Jun 20. PubMed PMID: 31229388)","journal-title":"Ann Emerg Med"},{"issue":"Suppl 1","key":"971_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00482-018-0331-5","volume":"34","author":"W H\u00e4user","year":"2020","unstructured":"H\u00e4user W, Schubert T, Scherbaum N, T\u00f6lle T (2020) Long-term opioid therapy of non-cancer pain : Prevalence and predictors of hospitalization in the event of possible misuse. Schmerz 34(Suppl 1):8\u201315. https:\/\/doi.org\/10.1007\/s00482-018-0331-5","journal-title":"Schmerz"},{"issue":"3","key":"971_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00482-020-00472-y","volume":"34","author":"W H\u00e4user","year":"2020","unstructured":"H\u00e4user\u00a0W, Bock\u00a0F, H\u00fcppe\u00a0M, Nothacker\u00a0M, Norda\u00a0H, Radbruch\u00a0L, Schiltenwolf\u00a0M, Schuler\u00a0M, T\u00f6lle\u00a0T, Viniol\u00a0A, Petzke\u00a0F, Koautoren f\u00fcr die Konsensusgruppe der 2.\u00a0Aktualisierung der S3-Leitlinie LONTS (2020) Empfehlungen der zweiten Aktualisierung der Leitlinie LONTS : Langzeitanwendung von Opioiden bei chronischen nicht-tumorbedingten Schmerzen. Schmerz 34(3):204\u2013244. https:\/\/doi.org\/10.1007\/s00482-020-00472-y","journal-title":"Schmerz"},{"issue":"9","key":"971_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11092506","volume":"11","author":"E Schulte","year":"2022","unstructured":"Schulte\u00a0E, Petzke\u00a0F, Spies\u00a0C, Denke\u00a0C, Sch\u00e4fer\u00a0M, Donner-Banzhoff\u00a0N, Hertwig\u00a0R, Wegwarth\u00a0O (2022) Self-Reported Practices and Emotions in Prescribing Opioids for Chronic Noncancer Pain: A\u00a0Cross-Sectional Study of German Physicians. J\u00a0Clin Med 11(9):2506. https:\/\/doi.org\/10.3390\/jcm11092506 (PMID: 35566644; PMCID: PMC9104176)","journal-title":"J Clin Med"},{"issue":"4","key":"971_CR7","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/j.pain.0000000000002412","volume":"163","author":"AD Grant","year":"2022","unstructured":"Grant\u00a0AD, Miller\u00a0MM, Anastas\u00a0TM, Quinn\u00a0P, Lok\u00a0B, Hirsh\u00a0AT (2022) Opioid-related risk perceptions in chronic pain: influence of patient gender and previous misuse behaviors. Pain 163(4):711\u2013718. https:\/\/doi.org\/10.1097\/j.pain.0000000000002412 (PubMed PMID: 34285152; PubMed Central PMCID: PMC8761212)","journal-title":"Pain"},{"key":"971_CR8","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.copsyc.2019.01.018","volume":"30","author":"RL Haffajee","year":"2019","unstructured":"Haffajee\u00a0RL, French\u00a0CA (2019) Provider perceptions of system-level opioid prescribing and addiction treatment policies. Curr Opin Psychol 30:65\u201373. https:\/\/doi.org\/10.1016\/j.copsyc.2019.01.018 (Epub 2019 Feb 4. Pub Med PMID: 30856591; PMCID: Pub Med Central PMC7482312)","journal-title":"Curr Opin Psychol"},{"key":"971_CR9","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s10389-022-01748-6","volume":"31","author":"NF Schrader","year":"2023","unstructured":"Schrader\u00a0NF, Niemann\u00a0A, Speckemeier\u00a0C et\u00a0al (2023) Prescription of opioid analgesics for non-cancer pain in Germany: study protocol for a\u00a0mixed methods analysis. J\u00a0Public Health 31:1909\u20131919. https:\/\/doi.org\/10.1007\/s10389-022-01748-6","journal-title":"Journal of Public Health"},{"key":"971_CR10","unstructured":"Deutsche Gesellschaft f\u00fcr Suchtforschung und Suchtherapie. S3- Leitlinie medikamentenbezogene St\u00f6rungen. https:\/\/www.dgppn.de\/publikationen\/leitlinien.html (last accessed on 24\u00a0March 2025)"},{"key":"971_CR11","unstructured":"Deutsche Gesellschaft f\u00fcr Schmerztherapie (2018) DGS-Praxisleitlinie f\u00fcr Substitutionsbehandlung bei Opioid-Fehlgebrauch in der Schmerztherapie. https:\/\/www.dgschmerzmedizin.de\/versorgung\/dgs-praxisleitlinien\/. Zugegriffen: 24. M\u00e4rz 2025"},{"key":"971_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.zefq.2026.01.001","volume":"201","author":"S Neusser","year":"2026","unstructured":"Neusser\u00a0S, Niemann\u00a0A, Schrader\u00a0N, Weitzel\u00a0M, Blase\u00a0N, Abels\u00a0C, Riederer\u00a0C, Nadstawek\u00a0J, Stra\u00dfmeir\u00a0W, Wasem\u00a0J (2026) Leitlinienempfehlungen und Versorgungsrealit\u00e4t aus \u00e4rztlicher Perspektive: Befragung von \u00c4rzt*innen zur Langzeitbehandlung chronischer nicht-tumorbedingter Schmerzen mit opioidhaltigen Analgetika. Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen 201:76\u201383. https:\/\/doi.org\/10.1016\/j.zefq.2026.01.001","journal-title":"Zeitschrift f\u00fcr Evidenz, Fortbildung und Qualit\u00e4t im Gesundheitswesen"},{"key":"971_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2023.1269018","volume":"4","author":"S Gal\u00e1n","year":"2023","unstructured":"Gal\u00e1n\u00a0S, de la Vega\u00a0R, Esteve\u00a0R, L\u00f3pez-Mart\u00ednez\u00a0AE, Fern\u00e1ndez Baena\u00a0M, Ram\u00edrez-Maestre\u00a0C (2023) Physicians\u2019 perception about predictors of opioid abuse in patients with chronic non-cancer pain: a\u00a0Delphi study. Front Pain Res 4:1269018. https:\/\/doi.org\/10.3389\/fpain.2023.1269018","journal-title":"Front Pain Res (Lausanne)"},{"key":"971_CR14","doi-asserted-by":"publisher","DOI":"10.1177\/2049463715579284","author":"H Blake","year":"2015","unstructured":"Blake\u00a0H, Leighton\u00a0P, van der Walt\u00a0G, Ravenscroft\u00a0A (2015) Prescribing opioid analgesics for chronic non-malignant pain in general practice - a\u00a0survey of attitudes and practice. Br J Pain. https:\/\/doi.org\/10.1177\/2049463715579284","journal-title":"British Journal of Pain"},{"key":"971_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-024-02474-6","volume":"25","author":"CE Keller","year":"2024","unstructured":"Keller\u00a0CE, Ashrafioun\u00a0MA, Neumann\u00a0A, van Klein\u00a0J, Fox\u00a0CH, Blondell\u00a0DB (2024) Practices, Perceptions, and concerns of primary care physicians about opioid dependence associated with the treatment of chronic pain. BMC Prim Care 25:236. https:\/\/doi.org\/10.1186\/s12875-024-02474-6","journal-title":"BMC Primary Care"},{"key":"971_CR16","doi-asserted-by":"crossref","unstructured":"Wilson HHK, Roxas BH, Lintzeris N, Harris MF. Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a\u00a0qualitative study using the theory of Planned Behaviour 2024","DOI":"10.1186\/s12875-024-02474-6"},{"key":"971_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00482-021-00582-1","volume":"36","author":"J Just","year":"2022","unstructured":"Just\u00a0J, Petzke\u00a0F, Scherbaum\u00a0N, Radbruch\u00a0L, Weckbecker\u00a0K, H\u00e4user\u00a0W (2022) Kritische Auseinandersetzung mit neuen Daten zur Pr\u00e4valenz von Opioidgebrauchsst\u00f6rungen bei Patienten mit chronischen Schmerzen in Deutschland. Schmerz 36:13\u201318. https:\/\/doi.org\/10.1007\/s00482-021-00582-1 (Epub 2021 Sep 10. Pub Med PMID: 34505947 ; Pub Med Central PMCID: PMC8821065)","journal-title":"Schmerz"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-026-00971-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-026-00971-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-026-00971-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:55:29Z","timestamp":1789397729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-026-00971-4"}},"subtitle":["Risikofaktoren und Handlungsans\u00e4tze bei Patienten mit chronischen nichttumorbedingten Schmerzen aus ambulant-\u00e4rztlicher Perspektive","Risk factors and action approaches in patients with chronic nontumor pain from an outpatient medical perspective"],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":17,"alternative-id":["971"],"URL":"https:\/\/doi.org\/10.1007\/s00482-026-00971-4","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.\u00a0Riederer ist Mitarbeiterin der DAK-Gesundheit. J.\u00a0Nadstawek und W.\u00a0Stra\u00dfmeir sind Vorsitzender des Vorstands bzw. Gesch\u00e4ftsf\u00fchrer des Berufsverbands der \u00c4rzte und Psychologischen Psychotherapeuten in der Schmerz- und Palliativmedizin in Deutschland\u00a0\u2013 BVSD e.\u202fV. S.\u00a0Neusser, A.\u00a0Niemann, N.F.\u00a0Schrader, N.\u00a0Blase, M.\u00a0Weitzel, C.\u00a0Abels, C.\u00a0Speckemeier, A.\u00a0Neumann und J.\u00a0Wasem geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}